JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2005;58:1121-1125; doi:10.1136/jcp.2004.024521
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ezzat, S
Right arrow Articles by Asa, S L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ezzat, S
Right arrow Articles by Asa, S L

REVIEW

The molecular pathogenetic role of cell adhesion in endocrine neoplasia

S Ezzat1, S L Asa2

1 Department of Medicine, University of Toronto, Endocrine Oncology Site Group, Mount Sinai and Princess Margaret Hospitals, Ontario Cancer Institute, University Health Network, Toronto, Ontario, Canada M5G-1X5
2 Department of Pathology and Laboratory Medicine, University of Toronto

Correspondence to:
Dr S Ezzat
600 University Avenue 437, Toronto, Ontario, Canada, M5G-1X5; sezzat{at}mtsinai.on.ca
ABSTRACT
It is becoming increasingly evident that cell adhesion is an important determinant of organised growth and the maintenance of architectural integrity. Indeed, reduced adhesiveness between cells and with the extracellular matrix is a hallmark of neoplastic growth. In neuroendocrine tissues, neural cell adhesion molecule is implicated in modulating cell growth, migration, and differentiation. This review will focus on the molecular pathways involving key growth factor receptors that govern normal adhesive forces. The extent to which disruption of these adhesive forces contributes to the tumorigenic process in neuroendocrine tissues will be highlighted. Validation of the functional relevance of these adhesive pathways will be discussed in light of targeted pharmacotherapeutic studies that are unmasking novel approaches to the treatment of neuroendocrine tumours.


Abbreviations: AdsFlt, adenoviral soluble vascular endothelial growth factor receptor 1; FGF, fibroblast growth factor; FGFR, fibroblast growth factor receptor; Ig, immunoglobulin; MEN, multiple endocrine neoplasia; NCAM, neural cell adhesion molecule; ptd, pituitary tumour derived

Keywords: fibroblast growth factor receptors; pituitary tumours; pancreatic neuroendocrine tumours; cell adhesion




This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
A. Di Florio, G. Capurso, M. Milione, F. Panzuto, R. Geremia, G. D. Fave, and C. Sette
Src family kinase activity regulates adhesion, spreading and migration of pancreatic endocrine tumour cells
Endocr. Relat. Cancer, March 1, 2007; 14(1): 111 - 124.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.